Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (7 quarters reported)
$233M in Q4 2018 → $114M now. Hover for any quarter.
As reported for the quarter ended June 30, 2020. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Allogene Therapeutics Inc. | 67.5% | Trimmed 22% | 1,798,163 | $77M |
| OP Oyster Point Pharma, Inc. | 19.7% | Unchanged | 778,468 | $22.5M |
| HM Homology Medicines Inc. | 10.3% | Unchanged | 770,845 | $11.7M |
| Sutro Biopharma Inc. | 2.5% | Trimmed 21% | 365,656 | $2.84M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 6 quarters.
quarter ended June 30, 2020 · filed August 04, 2020
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Allogene Therapeutics Inc. | Trimmed | −492,553 | −$21.1M | 67.5% |
| Sutro Biopharma Inc. | Trimmed | −99,207 | −$770K | 2.5% |
quarter ended March 31, 2020 · filed April 10, 2020
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| OP Oyster Point Pharma, Inc. | New | +778,468 | +$27.2M | 30.8% |
| OP Oyster Point Pharma, Inc. | Exited | −963,468 | −$23.5M | — |
| Allogene Therapeutics Inc. | Trimmed | −598,935 | −$11.6M | 50.3% |
| Sutro Biopharma Inc. | Trimmed | −530,716 | −$5.41M | 5.4% |
quarter ended December 31, 2019 · filed January 08, 2020
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Allogene Therapeutics, Inc. | Trimmed | −1,197,870 | −$31.1M | 59.8% |
| OP Oyster Point Pharma, Inc. | New | +963,468 | +$23.5M | 18.8% |
quarter ended September 30, 2019 · filed October 15, 2019
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Allogene Therapeutics Inc | Trimmed | −1,796,805 | −$49M | 82.9% |
quarter ended June 30, 2019 · filed July 10, 2019
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Allogene Therapeutics Inc | Trimmed | −1,796,807 | −$48.2M | 85.7% |
quarter ended March 31, 2019 · filed April 11, 2019
No position changes this quarter.
Loading...
